BQ-3020 TFA |
| Catalog No.GC60094 |
BQ-3020(TFA)은 ETB 수용체의 선택적 작용제로 소뇌에서 0.2 nM의 IC50으로 ETB 수용체에 대한 [125I]ET-1 결합을 억제하고 혈관수축을 유발한다.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
BQ-3020 (TFA) is a selective agonist of ETB receptor, inhibits [125I]ET-1 binding to ETB receptor with an IC50 of 0.2 nM in cerebellum, and causes vasoconstriction[1].
[1]. Ihara M, et al. A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptors. Life Sci. 1992;51(6):PL47-52.
Review for BQ-3020 TFA
Average Rating: 5 (Based on Reviews and 38 reference(s) in Google Scholar.)
Review for BQ-3020 TFA
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *